Stocks / Pharmaceuticals
TVTXPharmaceuticals
Travere Therapeutics, Inc.
$65.281d -1.9%5d -0.3%settled close · 2026-09-04
Mkt cap $2.5B (9/7)β 1.3652w $40–68Shares 92.2MInd. Pharmaceutical PreparationsNasdaq since 2003Emp. 497HQ San Diego, CAtravere.com
Who’s talkingIdea Scout · free
Who’s talking about TVTX
No tracked investor commentary on TVTX yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 28 Oct 2026
Confirmed date · consensus EPS -0.01. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where TVTX’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 4 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-04 | ||||||
| 2026-09-03 | ||||||
| 2026-09-01 | ||||||
| 2026-07-10 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
TVTX is in this morning’s Brief.
Get The Brief — $20/mo →